State of the Union News
SEE OTHER BRANDS

The most trusted news from the United States

State of the Union News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on State of the Union News.

Press releases published on June 13, 2025

Honeygirl Debuts 'Denim & Diamonds,' Inspired by Her Real-Life Love Story with Gin Blossoms Guitarist

Honeygirl Debuts 'Denim & Diamonds,' Inspired by Her Real-Life Love Story with Gin Blossoms Guitarist

Country Artist Honeygirl Debuts “Denim …

Best Holistic Life Names Mark Anthony JD, Psychic Explorer 2025 Visionary

Best Holistic Life Names Mark Anthony JD, Psychic Explorer 2025 Visionary

Honored for His Groundbreaking Work in Spiritual Exploration and Holistic Advocacy LOS ANGELES, CA, UNITED STATES, June 12, 2025 /⁨EINPresswire.com⁩/ -- Best Holistic Life Magazine proudly announces Mark Anthony, JD—renowned Psychic Explorer® and Oxford- …

Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025

Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025

Showcased 7 presentations at ISSCR 2025, including a featured oral presentation on first-in-human gene therapy for heart failure, powered by their proprietary human mini-Heart technology. FDA-backed human-based screening platform recognized as an animal- …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025

Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025

Interim analysis shows misetionamide is very well tolerated in combination with gemcitabine; rates of confirmed response, stable disease, and progression-free survival compare favorably with gemcitabine monotherapy BERWYN, PA, June 13, 2025 (GLOBE NEWSWIRE …

Grace Therapeutics to Participate in the 2025 BIO International Conference

Grace Therapeutics to Participate in the 2025 BIO International Conference

PRINCETON, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed …

Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants

Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced the sale of approximately …

Bitcoin Depot Adds to Bitcoin Treasury Holdings Amid Continued Market Momentum

Bitcoin Depot Adds to Bitcoin Treasury Holdings Amid Continued Market Momentum

ATLANTA, June 13, 2025 (GLOBE NEWSWIRE) -- Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced it has purchased additional Bitcoin (BTC) as part of its treasury strategy first initiated in …

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of its executive leadership team will …

Co-Founder of MidCap Howard Widra to Retire at the End of 2026

Co-Founder of MidCap Howard Widra to Retire at the End of 2026

BETHESDA, Md., June 13, 2025 (GLOBE NEWSWIRE) -- MidCap Financial (“MidCap”) today announced that Howard Widra, Co-Founder of MidCap and Partner at MidCap’s investment manager, Apollo Global Management, Inc. (“Apollo”), will retire from MidCap and Apollo …

180 Degree Capital Corp. Notes Filing of Updated Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc.

180 Degree Capital Corp. Notes Filing of Updated Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc.

MONTCLAIR, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) today noted the filing of an amended preliminary joint proxy statement/prospectus on Schedule 14A with the Securities and Exchange Commission …

Taseko Annual General Meeting Voting Results

Taseko Annual General Meeting Voting Results

VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the "Company") announces the voting results from its 2025 Annual General Meeting held Thursday, June 12, 2025 in …

Official Announcement: Legal Statement on Trademark and App Name by RBH

Official Announcement: Legal Statement on Trademark and App Name by RBH

San Diego, USA, June 13, 2025 (GLOBE NEWSWIRE) -- Today, RBH Infinity Exchange has issued a legal statement regarding its trademark and app name. The full text is as follows: This exchange and all its operations, services, products, and visual identifiers …

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates >50% improvement in pain and function in …

Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.250% Senior Unsecured Notes Due 2032

Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 5.250% Senior Unsecured Notes Due 2032

CINCINNATI, June 13, 2025 (GLOBE NEWSWIRE) -- Phillips Edison …

ALL4 Mining Launches User-Friendly Free Cloud Mining Platform to Support Cryptocurrency Enthusiasts Worldwide

ALL4 Mining Launches User-Friendly Free Cloud Mining Platform to Support Cryptocurrency Enthusiasts Worldwide

Buffalo, NY, June 13, 2025 (GLOBE NEWSWIRE) -- ALL4 Mining, a cloud mining platform founded in 2019, has announced the global expansion of its mining services, aiming to make cryptocurrency investment more accessible to both new and existing investors. …

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will …

Chart Industries to Present at J.P. Morgan Energy, Power, Renewables & Mining Conference

Chart Industries to Present at J.P. Morgan Energy, Power, Renewables & Mining Conference

ATLANTA, June 13, 2025 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, will present at the J.P. Morgan Energy, Power, Renewables …

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and …

Sunrise Realty Trust Announces Dividend for the Second Quarter 2025

Sunrise Realty Trust Announces Dividend for the Second Quarter 2025

WEST PALM BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS”), a lender on the TCG Real Estate platform, today announced its dividend for the quarter ending June 30, 2025. The Board of Directors of SUNS …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service